Advertisement
UK markets open in 24 minutes

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,241.04
    +39.77 (+0.23%)
     

  • CRUDE OIL

    82.97
    +0.16 (+0.19%)
     

  • GOLD FUTURES

    2,331.50
    -6.90 (-0.30%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,509.92
    -1,820.45 (-3.41%)
     

  • CMC Crypto 200

    1,390.78
    +8.21 (+0.59%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Property:

How to sell your home

Top tips from property investors

BUZZ-AstraZeneca PLC: Cancer pipeline boost

Reuters - UK Focus

** British drugmaker's U.S-listed shares up 2 pct at $75.85 after cancer drug pipeline boost

** Company's immuno-oncology medicine for colorectal cancer to be tested in mid-stage study

** Move (NasdaqGS: MOVE - news) opens up "a potentially multi-blockbuster opportunity", say analysts at UBS (NYSEArca: FBGX - news) , which rates the stock "buy"

** Shares (Frankfurt: DI6.F - news) also remain propped up by speculation of a possible renewed bid from Pfizer (NYSE: PFE - news)

** Up to Thursday's close, the stock had fallen 7.5 pct since May 16, the last trading day before AstraZeneca (NYSE: AZN - news) rejected Pfizer's sweetened and "final" offer (Reuters Messaging:; natalie.grover.thomsonreuters.com@reuters.net)